脳血管内BCIアクセスのための自律ロボットナビゲーション
Autonomous Robotic Navigation for Endovascular Brain-Computer Interface Access
脳静脈系における血管内BCIデバイス留置を目指し、強化学習と蛍光透視ガイド下で自律ロボットナビゲーションをin vitroで実証し、失敗予測も評価した。
詳しい要約
1. どんなもの?
2. 先行研究と比べてどこがすごい?
3. 技術・手法の肝は?
4. どうやって有効だと検証した?
5. 議論はある?
6. 次に読むべき論文は?
※ AIが要旨から生成した要約です。正確性は原文をご確認ください。
著者: Harry Robertshaw, Weijie Qi, Nikola Fischer, Alejandro Granados, Thomas C. Booth, Sam E. John
分類: cs.RO, cs.LG
原文アブストラクト
Endovascular brain-computer interfaces (BCIs) avoid craniotomy but require precise device delivery through anatomically variable cerebral veins. This work presents the first demonstration of in vitro autonomous robotic navigation for endovascular BCI access in the cerebral venous system. Soft Actor-Critic controllers were trained in silico for two sequential tasks spanning the right internal jugular vein to the superior sagittal sinus, using geometric augmentation of one training anatomy. Navigation was evaluated in a training anatomy and an anatomically unseen hold-out model over 250 in silico episodes and five fluoroscopy-guided in vitro robotic runs per task-anatomy condition, comprising 1,000 simulated episodes and 20 physical runs overall. Task recurrent predictors were also evaluated for online identification of impending navigation failure. In silico success rates for Tasks A and B were 85.6% and 98.4% in the training anatomy and 42.0% and 91.6% in the hold-out anatomy, respectively. Fourteen of 20 physical runs were successful (70% overall), including 80% success for Task B in the hold-out phantom. In silico the predictors detected 99.3-100.0% of failures with false-alarm rates of 0.8-6.7%. During in vitro evaluation, predicted risk increased before failed episodes, but elevated probabilities during some successful runs showed reduced calibration after transfer. These results demonstrate the feasibility of autonomous cerebral venous access and show how online failure prediction could support human oversight, while also identifying anatomical generalization and sim-to-real calibration as priorities before preclinical translation.